Birmingham-based IllumiCare, a pioneer in point-of-care healthcare information technology (HIT), has named Ralph Keiser as Chief Strategy Officer.

Keiser had been serving as a Board Advisor to the company for the past year. Prior to that, he was the Chief Executive Officer of EPSi, a division of Allscripts, until its sale to Roper Technologies in 2020. He brings 40 years of experience in HIT, having held management roles in a number of companies including Cerner, Eclipsys, Allscripts and Deloitte.

IllumiCare will benefit from Keiser's expertise as it continues to further itself as a leader in the HIT sector and expands into Life Sciences. In his new role, Keiser will be leading the development and execution of commercial strategy for 2022 and beyond. His immediate priority will be the successful launch of IllumiCare's new clinical trial recruitment app.